Agios Pharmaceuticals
AGIO
$34.34
Share price
-1.89%
Change (1 day)
32.18%
Change (1 year)
Categories
Agios Pharmaceuticals (AGIO) - Net assets
Net assets on the balance sheet as of December 2023 : $0.81 B
According to Agios Pharmaceuticals
's latest financial reports the company has $0.81 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Agios Pharmaceuticals - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.81 B | -26.33% |
| 2022-12-31 | $1.10 B | -14.8% |
| 2021-12-31 | $1.29 B | 223.4% |
| 2020-12-31 | $0.39 B | -37.63% |
| 2019-12-31 | $0.64 B | -6.84% |
| 2018-12-31 | $0.68 B | 83.1% |
| 2017-12-31 | $0.37 B | 4.72% |
| 2016-12-31 | $0.35 B | 3.9% |
| 2015-12-31 | $0.34 B | -18.67% |
| 2014-12-31 | $0.42 B | 222.76% |
| 2013-12-31 | $0.13 B | 199.52% |
| 2012-12-31 | $43.89 M | -30.48% |
| 2011-12-31 | $63.14 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 10,909.36% | 🇺🇸 USA |
 Eli Lilly LLY | $12.89 B | 1,490.27% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.71 B | 1,961.33% | 🇬🇧 UK |
 Xencor XNCR | $0.66 B | -17.49% | 🇺🇸 USA |
 Exelixis EXEL | $2.12 B | 162.39% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $5.07 B | 525.61% | 🇺🇸 USA |